Cargando…

Hyperglycemia and Death in Cystic Fibrosis–Related Diabetes

OBJECTIVE: Diabetes is common in cystic fibrosis and increases the risk of death, yet the role of hyperglycemia remains unproven. An association between glycemia and mortality would provide compelling evidence to support glucose lowering in cystic fibrosis–related diabetes (CFRD). RESEARCH DESIGN AN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adler, Amanda I., Shine, Brian, Haworth, Charles, Leelarathna, Lalantha, Bilton, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120212/ https://www.ncbi.nlm.nih.gov/pubmed/21593303 http://dx.doi.org/10.2337/dc10-2289

Ejemplares similares

Diabetes as a Determinant of Mortality in Cystic Fibrosis
por: Chamnan, Parinya, et al.
Publicado: (2010)

Genetic Determinants and Epidemiology of Cystic Fibrosis–Related Diabetes: Results from a British cohort of children and adults
por: Adler, Amanda I., et al.
Publicado: (2008)

Insulin Therapy to Improve BMI in Cystic Fibrosis–Related Diabetes Without Fasting Hyperglycemia: Results of the Cystic Fibrosis Related Diabetes Therapy Trial
por: Moran, Antoinette, et al.
Publicado: (2009)

Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study
por: Tanner, Kamaryn T., et al.
Publicado: (2022)

Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot
por: Thabit, Hood, et al.
Publicado: (2016)

Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
por: Hilliam, Yasmin, et al.
Publicado: (2017)

COVID-19: Impact of and on Diabetes
por: Schofield, Jonathan, et al.
Publicado: (2020)

Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes
por: Jones, Gregory C., et al.
Publicado: (2016)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective
por: Leelarathna, Lalantha, et al.
Publicado: (2018)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
por: Floto, R Andres, et al.
Publicado: (2016)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Glycaemic variability: The under‐recognized therapeutic target in type 1 diabetes care
por: Wilmot, Emma G., et al.
Publicado: (2019)

The changing demography of the cystic fibrosis population: forecasting future numbers of adults in the UK
por: Keogh, Ruth H., et al.
Publicado: (2020)

Cystic Fibrosis-Related Diabetes
por: Kayani, Kayani, et al.
Publicado: (2018)

COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes
por: Mason, Kelly, et al.
Publicado: (2021)

Genetic Modifiers of Cystic Fibrosis–Related Diabetes
por: Blackman, Scott M., et al.
Publicado: (2013)

The role of modulators in cystic fibrosis related diabetes
por: Merjaneh, Lina, et al.
Publicado: (2021)

Letter to the Editor Regarding: Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes
por: Baird, John Scott
Publicado: (2016)

Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012–2016 Experience
por: Higgins, Mark, et al.
Publicado: (2020)

Cystic Fibrosis-Related Diabetes in Poland
por: Rachel, Marta, et al.
Publicado: (2022)

Health State Utility Data in Cystic Fibrosis: A Systematic Review
por: Mohindru, Bishal, et al.
Publicado: (2019)

Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England
por: Prabhu Navis, Joshi, et al.
Publicado: (2020)

Cystic fibrosis-related diabetes and lung disease: an update
por: Prentice, Bernadette J., et al.
Publicado: (2021)

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis
por: Savi, Daniela, et al.
Publicado: (2015)

Future therapies for cystic fibrosis
por: Allen, Lucy, et al.
Publicado: (2023)

Results from an online survey of adults with cystic fibrosis: Accessing and using life expectancy information
por: Keogh, Ruth H., et al.
Publicado: (2019)

Optimising inhaled mannitol for cystic fibrosis in an adult population
por: Flume, Patrick A., et al.
Publicado: (2015)

Data Resource Profile: The UK Cystic Fibrosis Registry
por: Taylor-Robinson, David, et al.
Publicado: (2018)

Cystic fibrosis-related diabetes: The unmet need
por: Pozo, Leonardo, et al.
Publicado: (2020)

The Potential Causes of Cystic Fibrosis-Related Diabetes
por: Coderre, Lise, et al.
Publicado: (2021)

Cystic fibrosis related diabetes (CFRD) prognosis
por: Sandouk, Zahrae, et al.
Publicado: (2021)

Cystic fibrosis-related diabetes: The patient perspective()
por: Mason, Kelly A., et al.
Publicado: (2021)

Prevalence of Nontuberculous Mycobacteria in Cystic Fibrosis Clinics, United Kingdom, 2009
por: Seddon, Paul, et al.
Publicado: (2013)

No Relation Between Cystic Fibrosis–Related Diabetes and Type 1 Diabetes Autoimmunity
por: Gottlieb, Peter A., et al.
Publicado: (2012)

Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care
por: Carr, Matthew J, et al.
Publicado: (2022)

Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review
por: Stanford, Gemma E., et al.
Publicado: (2022)

Improving performance in the detection and management of cystic fibrosis-related diabetes in the Mountain West Cystic Fibrosis Consortium
por: Liou, Theodore G, et al.
Publicado: (2016)

MON-LB114 CGM in Cystic Fibrosis Patients to Predict Cystic Fibrosis-Related Diabetes Onset
por: Mei Hsia Pu, Mariana Zorron, et al.
Publicado: (2020)

Understanding the Pancreatic Islet Microenvironment in Cystic Fibrosis and the Extrinsic Pathways Leading to Cystic Fibrosis Related Diabetes
por: Al-Selwi, Yara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n8umvtkc88reeguafied2jjopp